Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Juvederm Users: Cosmetic Dermatologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
August 4, 2008
there are some, but basics in dermatology are why we are good at the cosmetics
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
1. Dermatologists need to keep the basics in dermatology2. The net return on cosmetics is much better than the net return3. It is important to create a balance that gives an opportunity for dermatology patients while treating cosmetics.4.It may be that many dermatologists are still new in cosmetics.5....
Sunil DhawanAugust 1, 2008
Will access to dermatology care suffer with increased cosmetic procedures ?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
 This article is important in that it describes a growing trend among dermatologists to offer a higher level of "customer service" for their cash paying cosmetic patients. This has contributed in a small way to the long waits for non cosmetic dermatology patients to be able to see a dermatologist....
Robert FrankJuly 31, 2008
Dermatologists? I worry more about the Family practitioners, Ob-Gyns, and Internists...
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
As insurance reimbursements decline, everyone suddenly thinks they're a cosmetic surgeon.
July 21, 2008
Doctors are in the middle of a large financial battle.
Analysis of: Pricey Drugs Put Squeeze on Doctors | online.wsj.com
Author: GLG Expert Contributor
Unfortunately, the physicians have to buy the drugs and it pits the docs in the middle of the money war of pharmaceuticals.     The battle in between is getting too rough and expensive.          
Sunil DhawanJuly 18, 2008
Will prescription drug spending decreases affect dermatology?
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a worrying trend for branded  pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived...
Adam SchaffnerJuly 8, 2008
Evolence: Will this New "Advanced" Collagen Filler Take Hold?
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
Evolence is an injectable filler material that is made by an "advanced collagen GLYMATRIX™ Technology."  Collagen has generally fallen out of favor amongst aesthetic physicians due to its short duration of action.  Evolence will have to demonstrate that it is superior to the plethora...
Alan ZaccariaJuly 8, 2008
And yet, another filler? Is this the Holy Grail?
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
Over the past few years, noninvasive cosmetic procedures have skyrocketed.  Soft tissue injectable fillers are among those procedures that are rapidly growing.  Up until now, hyaluronic acid (HA) fillers have been the mainstay.  With the emergence of Envolence, we have a new twist on...
Sunil DhawanJuly 7, 2008
Protopic use can prevent relapse
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it confirms a commonly used method in clinical dermatology practice. Namely that of using Protopic for longer term maintenance to prevent flares, and to act as a topical steroid sparing agent. This has been done since the introduction of Protopic, and among dermatologists...
Sunil DhawanJuly 7, 2008
New uses for old meds- benefit or drawback?
Analysis of: One drug, many uses. Good idea? | www.indystar.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it describes a growing concern that is not well known to the investment community or the public. Due to increased pressure from the generic companies, the FDA, and the public many companies are finding new uses for older medications. This is very true in dermatology...
Sunil DhawanJuly 2, 2008
Evolence Approval- what effect will it have on the filler market
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 156

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-08-30T05:45:15.877